Browse the corpus

Diphenoxylate and atropine, a medication combination for managing diarrhea, present a valuable therapeutic option for healthcare professionals. Operating within the antimotility class of drugs, diphenoxylate exhibits significant efficacy in addressing both acute and chronic episodes of diarrhea. This continuing medical education (CME) activity centers on elucidating the indications, action, and contraindications of diphenoxylate/atropine, emphasizing its pivotal role in clinical practice. The comprehensive exploration of its mechanism of action, adverse event profile, and contraindications equips healthcare team members with vital insights necessary for optimizing patient care in gastrointestinal conditions. By fostering a deeper understanding of diphenoxylate/atropine's dosing, monitoring, clinical toxicology, and relevant interactions, this educational initiative empowers healthcare professionals to navigate the complexities inherent in managing diarrhea and related ailments. Recognizing the interprofessional healthcare team's indispensable role, this program aims to furnish practitioners with evidence-based medicine, enabling them to make informed decisions and tailor dosage regimens to individual patient needs. Through this initiative, healthcare professionals are poised to enhance patient outcomes and uphold the highest standards of care in gastrointestinal disorders treated with diphenoxylate and atropine. Objectives: Identify the mechanism of action of diphenoxylate and atropine in gastrointestinal disorders. Evaluate the adverse effects of diphenoxylate and atropine. Determine the appropriate monitoring of diphenoxylate and atropine. Implement effective collaboration and communication among interprofessional team members to improve outcomes and treatment efficacy for patients who might benefit from diphenoxylate and atropine. Access free multiple choice questions on this topic.

Signs and Symptoms of Overdose Overdose can be life-threatening. The presentation can be delayed for up to 30 hours as the drug decreases gastric emptying and takes time to reach toxic levels in the blood. Symptoms vary from anticholinergic to opioid toxidromes, like respiratory depression, tachypnea, coma, delirium, lethargy, hyperthermia, tachycardia, dryness of mucous membranes, mydriasis or miosis, encephalopathy, and seizures.[22] The respiratory depression might correlate with the accumulation of difenoxin, which is an active metabolite of diphenoxylate. Management of Overdose The recommended treatment for toxicity is naloxone if the patient exhibits respiratory depression. Considerations may be given for gastric lavage and administration of activated charcoal if indicated. Close monitoring for 24 hours is advisable in significant overdoses or those with concerning symptoms. Naloxone is a pure mu (opioid) receptor antagonist that reverses the opioid toxicity effects caused by diphenoxylate toxicity. Recurrent episodes of respiratory depression require repeated doses of naloxone or infusion. Physostigmine should be considered if the patient is showing signs of atropine toxicity.[23][24]

The management of diphenoxylate/atropine overdose requires an interprofessional team of healthcare professionals, including physicians, nurse practitioners, physician assistants, nurses, laboratory technicians, and pharmacists. Inefficient management of diphenoxylate/atropine overdose significantly increases morbidity and mortality rates. The moment the triage nurse obtains a history of suspected diphenoxylate/atropine overdose, the emergency department clinician and the assigned nurse are responsible for coordinating the care, which includes the following: Ordering and obtaining drug levels in the serum and or urine Monitor the patient for signs and symptoms of respiratory depression Consider treatments to help limit the absorption of the drug in the body Consult with the pharmacist about the use of activated charcoal and naloxone Consult with a toxicologist and nephrologist on further management, including dialysis Consult the radiologist about imaging tests to ensure the patient has not swallowed any drug packages Consult with the intensivist about critical care and monitoring in the MICU/IMC The management of diphenoxylate/atropine overdose does not stop in the emergency department. Once the patient stabilizes, clinicians must determine how and why the patient overdosed. Consult with a mental health counselor if this was an intentional act and assess risk factors for self-harm. Further, the possibility of addiction and withdrawal symptoms have to be considered. The morbidity of diphenoxylate/atropine overdose can only be reduced through the collaborative efforts of an interprofessional team. Initial short-term data reveal that the use of naloxone can be life-saving. The long-term outcomes of detoxification and drug rehabilitation remain guarded. An interprofessional team approach and excellent communication between clinicians, pharmacists, nurses, and specialists are necessary to optimize patient outcomes with diphenoxylate/atropine therapy while minimizing the risk of overdose.